Phase 1 and Phase 2 Drug Metabolism and Bile Acid Production of HepaRG Cells in a Bioartificial Liver in Absence of Dimethyl Sulfoxide

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Drug Metabolism And Disposition

• Publication date

  2013-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/dmd.112.049098PMID 23238784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vitro Evaluation of Major In Vivo Drug Metabolic Pathways Using Primary Human Hepatocytes and HepaRG Cells in Suspension and a Dynamic Three-Dimensional Bioreactor System

  2012cited by this paper
• Liver Progenitor Cell Line HepaRG Differentiated in a Bioartificial Liver Effectively Supplies Liver Support to Rats with Acute Liver Failure

  2012influential reference
• The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human

  2012cited by this paper
• Cytochrome P450-Dependent Metabolism in HepaRG Cells Cultured in a Dynamic Three-Dimensional Bioreactor

  2011cited by this paper
• The HepaRG cell line is suitable for bioartificial liver application.

  2011influential reference
• HepaRG cells: A human model to study mechanisms of acetaminophen hepatotoxicity

  2011cited by this paper
• Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification.

  2010cited by this paper
• Stable overexpression of Pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application

  2010cited by this paper
• Liver injury caused by drugs: an update.

  2010cited by this paper
• Running title page Running title : Functional stability of CYP P 450 enzymes in HepaRG cells

  2009cited by this paper
• Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1alpha involvement in CYP3A4 repression.

  2009cited by this paper
• Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells.

  2009cited by this paper
• HepaRG Cells as an in Vitro Model for Evaluation of Cytochrome P450 Induction in Humans

  2008cited by this paper
• Enhanced oxygen availability improves liver-specific functions of the AMC bioartificial liver.

  2008cited by this paper
• Bile acid transporters in health and disease

  2008cited by this paper
• Transdifferentiation of hepatocyte‐like cells from the human hepatoma HepaRG cell line through bipotent progenitor

  2007influential reference
• Time-Related Analysis of Metabolic Liver Functions, Cellular Morphology, and Gene Expression of Hepatocytes Cultured in the Bioartificial Liver of the Academic Medical Center in Amsterdam (AMC-BAL)

  2007cited by this paper
• Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats.

  2006cited by this paper
• Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors.

  2006cited by this paper
• Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line.

  2006influential reference
• EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS

  2006cited by this paper
• Assessment of in vitro applicability of reversibly immortalized NKNT-3 cells and clonal derivatives.

  2006cited by this paper
• Assessment and Improvement of Liver Specific Function of the AMC-Bioartificial Liver

  2005cited by this paper
• The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4

  2003cited by this paper
• Mechanisms of Hepatic Transport of Drugs: Implications for Cholestatic Drug Reactions

  2002cited by this paper
• Infection of a human hepatoma cell line by hepatitis B virus

  2002cited by this paper
• Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor.

  2001cited by this paper
• Zonal down‐regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver

  2000cited by this paper
• Rapid analysis of conjugated bile acids in plasma using electrospray tandem mass spectrometry: Application for selective screening of peroxisomal disorders

  1999cited by this paper
• The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver*

  1998cited by this paper
• Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphateglucuronosyltransferase

  1995cited by this paper
• Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase.

  1994cited by this paper
• Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities

  1985cited by this paper

• The Role of Hepatobiliary Transporters in Bile Acid Homeostasis

  2025cites this paper
• Set up of a human 3D liver multicellular model for chemical high-throughput toxic hazard assessment

  2025cites this paper
• Development of a human liver microphysiological co-culture system for higher throughput chemical safety assessment.

  2024cites this paper
• Synthetic augmentation of bilirubin metabolism in human pluripotent stem cell-derived liver organoids

  2023cites this paper
• A microfluidic thyroid-liver platform to assess chemical safety in humans.

  2022cites this paper
• Modeling Nonalcoholic Fatty Liver Disease on a Liver Lobule Chip with Dual Blood Supply.

  2021cites this paper
• Constitutive Androstane Receptor-Mediated Inhibition of Metformin on Phase II Metabolic Enzyme SULT2A1

  2021cites this paper
• Advanced 3D Cell Culture Techniques in Micro-Bioreactors, Part I: A Systematic Analysis of the Literature Published between 2000 and 2020

  2020cites this paper
• Advanced 3D Cell Culture Techniques in Micro-Bioreactors, Part II: Systems and Applications

  2020cites this paper
• Genome-wide expression profiling reveals increased stability and mitochondrial energy metabolism of the human liver cell line HepaRG-CAR

  2020cites this paper
• Characterization Of Cytosolic Sulfotransferase Expression And Regulation In Human Liver And Intestine

  2019cites this paper
• Biotechnology and Bioengineering

  2019cites this paper
• The role of mitochondria in human liver cell line differentiation for bioartificial livers

  2019cites this paper
• Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization

  2018cites this paper
• Regulation of Cytosolic Sulfotransferases in Models of Human Hepatocyte Development

  2018cites this paper
• A practice-changing culture method relying on shaking substantially increases mitochondrial energy metabolism and functionality of human liver cell lines

  2018cites this paper
• Stable Overexpression of the Constitutive Androstane Receptor Reduces the Requirement for Culture with Dimethyl Sulfoxide for High Drug Metabolism in HepaRG Cells

  2017cites this paper
• Comparative study of visible light polymerized gelatin hydrogels for 3D culture of hepatic progenitor cells

  2017cites this paper
• Performance of cold-preserved rat liver Microorgans as the biological component of a simplified prototype model of bioartificial liver

  2016cites this paper
• Applications of Microarray Bioprinting

  2016cites this paper
• Engineering EMT using 3D micro-scaffold to promote hepatic functions for drug hepatotoxicity evaluation.

  2016cites this paper
• Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes.

  2015cites this paper
• HepaRG microencapsulated spheroids in DMSO-free culture: novel culturing approaches for enhanced xenobiotic and biosynthetic metabolism

  2015cites this paper
• A ready-to-use, versatile, multiplex-able three-dimensional scaffold-based immunoassay chip for high throughput hepatotoxicity evaluation.

  2015cites this paper
• Interaction between iron oxide nanoparticles and HepaRG cells: a preliminary in vitro evaluation

  2015cites this paper
• Improved predictive models for pre-clinical drug toxicity studies

  2015cites this paper
• Development of 3D in vitro models for prediction of hepatic metabolism and toxicity

  2015cites this paper
• Oxo‐vanadium(IV) Schiff base complex supported on modified MCM‐41: a reusable and efficient catalyst for the oxidation of sulfides and oxidative S–S coupling of thiols

  2015cites this paper
• Novel Bioreactor Design: Development of a Bioartifical Liver for Multiplexing with Serial Organ Systems for Pharmaceutical Testing

  2014influential citation
• Consideration of Metabolism in In Vitro Cellular Systems

  2014cites this paper
• PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.

  2014cites this paper
• A strategy for integrating essential three-dimensional microphysiological systems of human organs for realistic anticancer drug screening

  2014cites this paper
• Bioreactor technologies to support liver function in vitro.

  2014cites this paper
• The newly established human liver cell line: a potential cell source for the bioartificial liver in the future

  2013cites this paper